The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance

Abdelmalak, M; Singh, R; Anwer, M; Ivanchenko, P; Randhawa, A; Ahmed, M; Ashton, AW; Du, YM; Jiao, XM; Pestell, R

Jiao, XM; Pestell, R (通讯作者)，Baruch S Blumberg Inst, Penn Canc & Regenerat Med Res Ctr, 3805 Old Easton Rd, Doylestown, PA 18902 USA.;Jiao, XM; Pestell, R (通讯作者)，Xavier Univ, Sch Med, 23 Santa Helenastr, Oranjestad, Aruba.;Pestell, R (通讯作者)，Wistar Canc Ctr, Philadelphia, PA 19107 USA.

CANCERS, 2022; 14 (21):

Abstract

Simple Summary Cyclin-dependent kinase inhibitors (palbociclib (Ibrance), ribociclib (Kisqali), and abemaciclib (Verzenio)), targeting aberrant cell-c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索